menu
º»¹®¹Ù·Î°¡±â
Èñ±Í³­Ä¡Áúȯ¿¬±¸¼¾ÅÍ ±è³²¼ø ¼¾ÅÍÀå

±è³²¼ø¼¾ÅÍÀå

´ã´ç¾÷¹«

  • À¯Àüü ±â¹Ý Áúȯ Áø´Ü/Ä¡·á Ÿ°Ù ´ë·® ¹ß±¼ ¹× ±â´É/±âÀü ¿¬±¸
  • "Çѱ¹Àΰ£À¯ÀüÀÚÀºÇà" ¿î¿µ
¸ñÇ¥
  • ºòµ¥ÀÌÅÍ ±â¹Ý Èñ±Í³­Ä¡¼º ½Å°æ°èÁúȯÀÇ Á¤¹Ð¡¤¸ÂÃãÀǷῬ±¸ ÀÎÇÁ¶ó ±¸Ãà
  • Èñ±Í³­Ä¡¼º ½Å°æ°èÁúȯÀÇ Á¤¹Ð¡¤¸ÂÃã Áø´Ü/Ä¡·á ¿øÃµ±â¼ú °³¹ß
¿¬±¸ºÐ¾ß
  • Èñ±Í³­Ä¡¼º ½Å°æ°èÁúȯÀÇ °íǰÁú ÀÓ»ó½Ã·á ÀÓ»óÁ¤º¸ À¯ÀüüÁ¤º¸ È®º¸
  • Èñ±Í³­Ä¡¼º ½Å°æ°èÁúȯÀÇ Çѱ¹ÀÎ À¯ÀüüǥÁغ¯ÀÌÁöµµ ÀÛ¼º ¹× °í±Þ ÅëÇÕ DB ±¸Ãà
  • Èñ±Í³­Ä¡¼º ½Å°æ°èÁúȯ Á¤¹Ð Áø´Ü ¿øÃµ±â¼ú °³¹ß
  • Èñ±Í³­Ä¡¼º ½Å°æ°èÁúȯ Á¤¹Ð ¸ÂÃã Ä¡·á¿ë Ÿ°Ù ¹ß±¼ ¹× ±â´É/±âÀü ±Ô¸í
¿¬±¸¼º°ú
  • ³ú ¹ß´ÞÀå¾Ö ¿øÀÎ ½Å±Ô º¯ÀÌ ¹ß°ß ¹× µ¿¹° ¸ðµ¨ °³¹ß
    • ½Å°æ¼¼Æ÷ ƯÀÌÀûÀÎ KIF1A ¸ðÅÍ µµ¸ÞÀο¡ Á¸ÀçÇÏ´Â ´Ù¾çÇÑ de novo µ¹¿¬º¯ÀÌ·Î ÀÎÇÏ¿© ÁöÀûÀå¾Ö, °­Á÷¼º ¸¶ºñ, ½Å°æÃà»öµ¹±â Àå¾Ö ¹× ¼Ò³ú À§ÃàÁõÀÌ À¯¹ßµÊÀ» ±Ô¸í
    • ¼Ò¾Æ°£Áú, ÀÚÆó ¹× ÁöÀûÀå¾Ö¸¦ À¯¹ßÇÏ´Â TSC À¯Àü¼º ³ú ¹ß´ÞÁúȯÀÇ in vivo µ¿¹°¸ðµ¨ Á¦ÀÛ
    • in vitro ½Å°æÁٱ⼼Æ÷ ¹è¾ç ½Ã½ºÅÛÀ» ÀÌ¿ëÇÏ¿© ³ú ¹ß´ÞÁúȯ Áø´Ü Ç¥ÁöÀÚ ¹ß±¼À» À§ÇÑ ½Ã½ºÅÛ ±¸Ãà ¿Ï·á
  • Áúȯ ƯÀÌÀû ´ë¿ë·® NGS À¯Àüü µ¥ÀÌÅÍ »ý»ê ¹× ºÐ¼® ÆÄÀÌÇÁ ¶óÀÎ ±¸Ãà
    • ´ë¿ë·® NGS À¯Àüü µ¥ÀÌÅÍ¿Í ´ÙÁß ÀÌÇü ¹ÙÀÌ¿À ºòµ¥ÀÌÅÍ Ã³¸®, °¡°ø ¹× ºÐ¼®À» À§ÇÑ ½Ã½ºÅÛ °³¹ß ¿Ï·á
    • ÀÓ»ó ½Ã·á/ Public DBÀÇ NGS µ¥ÀÌÅ͸¦ ÀÌ¿ëÇÏ¿© Áúȯ °ü·Ã ´Ù¾çÇÑ SNV/INDEL Èĺ¸ µµÃâ ¹× À¯Àüü Á¤º¸ ÅëÇÕ ºÐ¼®/Á¤º¸ Ç¥ÁØÈ­ ±â¼ú È®¸³
    • Áúȯ °ü·Ã À¯Àüüº¯ÀÌÁöµµ ¹× DB ±¸Ãà
  • À¯Àüü ±â¹Ý Áúȯ Ä¡·áÁ¦ °³¹ßÀ» À§ÇÑ Å¸°Ù ¹ß±¼ ¹× ±âÀü ¿¬±¸
    • ½Å±Ô TRAILÇ×¾ÏÁ¦ ³»¼º À¯ÀüÀÚ TIPRLÀÇ TRAIL sensitizer·Î¼­ ¿ªÇÒ Á¦½Ã
    • Site specificÇÑ Histone methylation ±â¼ú º¸À¯
    • ½Å±Ô GPCR ´Ü¹éÁú ¹× ÀÌÀÇ ¿ëµµ¿¡ °üÇÑ Æ¯Çã µî·Ï (¹Ì±¹, À¯·´, Áß±¹)
    • Ç÷Áß ÀÚ°¡¸é¿ª Ç×ü¿¡ ±Ù°ÅÇÑ »ýüÁöÇ¥ÀÇ ¹ß±¼ ¹× ¾Ï Áø´Ü¹ý°³¹ß ¹× »ç¾÷È­ ½Ç½Ã
    • Áúȯ Ÿ°ÙÀÇ ±â´É¿¬±¸¿¡ ÇÊ¿äÇÑ Àΰ£ÀüÀåÀ¯ÀüÀÚŬ·Ð ¹× ¹ßÇöŬ·Ð ÀÎÇÁ¶ó ±¸Ãà
¿ì¼ö³í¹®
  • Osteopontin production by TM4SF4 signaling drives a positive feedback autocrine loop with the STAT3 pathway to maintain cancer stem cell-like properties in lung cancer cells.
    • Oncotarget. 8(60):101284-101297.
    • Eun Wie Cho (Co-corresponding)
  • Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.
    • Oncotarget. 8(68):112610-112622.
    • Nam-Soon Kim (Co-corresponding)
  • Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene.
    • Sci Rep. 7(1):12527.
    • Jae-Ran Lee (Co-corresponding)
  • Ottogi inhibits Wnt/¥â-catenin signaling by regulating cell membrane trafficking of Frizzled8.
    • Sci Rep. 7(1):13278.
    • Nam-Soon Kim (Co-corresponding)